Newswise — "While investors may be feeling gun-shy following this weekend's news, now might be the time to explore companies that seem a little off the beaten path, innovative outfits in the small- and micro-cap spaces," says Dian Griesel, author of the forthcoming Uncapped, and founder and CEO of the Investor Relations Group. "Even when times are rough on Wall Street, America never stops innovating or investing in our future."
Indeed, approximately 50% of all prescription drugs most Americans find in their medicine cabinets were initially discovered by small biotech companies. "Many tech and biotech companies in the micro-cap space are great examples of where the real cutting-edge research and development is occurring," says Griesel. "In all likelihood, the micro-cap space is where we will see the emergence of things like oral insulin, cancer vaccines, and the next wave of nanotechnology. These companies act like a crystal ball for the future, and the well-positioned investor has the opportunity to reap windfalls."
For those covering this news, the Investor Relations Group makes available company founder and CEO Dian Griesel, author of the forthcoming Uncapped, to discuss a variety of topics including:
"¢ When, if ever, are government bailouts of private financial institutions necessary in order to help stabilize the nation's economy?"¢ Following the collapses of Bear Stearns, Lehman Brothers, and Merrill Lynch, will we see renewed calls for increased government regulation on Wall Street?"¢ Have we hit the floor on the financial repercussions stemming from the housing mortgage crisis? "¢ What opportunities exist in the current marketplace for investors?"¢ Why should wary investors consider putting money in relatively unproven companies?"¢ What do investors need to know before taking a position in small- and micro-cap companies?"¢ What are some recent success stories in the small- and micro-cap space?"¢ How is the small- and micro-cap sector emblematic of America's entrepreneurial zeal?
Expert Biography " Dian GrieselDian Griesel is the founder and CEO of the Investor Relations Group (IRG), an investor relations and corporate communications company established in 1995. A partner at the Quanstar Group, Griesel is also the author of Capitalization Success, The 101 Platinum-plus Rules of Media Engagement, and the forthcoming Uncapped.
About The Investor Relations Group, Inc.The Investor Relations Group, Inc. (IRG) offers a full-service corporate communications program designed to suit the many unique needs of Alternative Public Offering (APO) companies. The program utilizes a proprietary, targeted approach to reach institutional investors, analysts, and the media-at-large.
For more information about the Investor Relations Group, please visit http://www.investorrelationsgroup.com.
RSS